DK1513800T3 - Benzoylureido-kanelsyrederivater, fremgangsmåde til deres anvendelse - Google Patents

Benzoylureido-kanelsyrederivater, fremgangsmåde til deres anvendelse

Info

Publication number
DK1513800T3
DK1513800T3 DK03732438T DK03732438T DK1513800T3 DK 1513800 T3 DK1513800 T3 DK 1513800T3 DK 03732438 T DK03732438 T DK 03732438T DK 03732438 T DK03732438 T DK 03732438T DK 1513800 T3 DK1513800 T3 DK 1513800T3
Authority
DK
Denmark
Prior art keywords
benzoylureido
acid derivatives
cinnamic acid
derivatives
benzoylureidocinnamate
Prior art date
Application number
DK03732438T
Other languages
English (en)
Inventor
Karl-Ulrich Wendt
Karl Schoenafinger
Elisabeth Defossa
Dieter Kadereit
Roedern Erich Von
Hans-Joerg Burger
Andreas Herling
Thomas Klabunde
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of DK1513800T3 publication Critical patent/DK1513800T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/46—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylureas
    • C07C275/48—Y being a hydrogen or a carbon atom
    • C07C275/54—Y being a carbon atom of a six-membered aromatic ring, e.g. benzoylureas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
DK03732438T 2002-06-07 2003-05-22 Benzoylureido-kanelsyrederivater, fremgangsmåde til deres anvendelse DK1513800T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10225635A DE10225635C1 (de) 2002-06-07 2002-06-07 N-Benzoylureido-Zimtsäurederivate, Verfahren zu deren Herstellung und deren Verwendung
PCT/EP2003/005355 WO2003104188A1 (de) 2002-06-07 2003-05-22 N-benzoylureido-zimtsäurederivate, verfahren zu deren herstellung und deren verwendung

Publications (1)

Publication Number Publication Date
DK1513800T3 true DK1513800T3 (da) 2007-03-26

Family

ID=29594346

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03732438T DK1513800T3 (da) 2002-06-07 2003-05-22 Benzoylureido-kanelsyrederivater, fremgangsmåde til deres anvendelse

Country Status (26)

Country Link
EP (1) EP1513800B1 (da)
JP (1) JP4398859B2 (da)
KR (1) KR20050004295A (da)
CN (1) CN1659137A (da)
AT (1) ATE345326T1 (da)
AU (1) AU2003238373A1 (da)
BR (1) BR0311646A (da)
CA (1) CA2488760A1 (da)
CY (1) CY1106003T1 (da)
DE (2) DE10225635C1 (da)
DK (1) DK1513800T3 (da)
ES (1) ES2277082T3 (da)
HR (1) HRPK20041161B3 (da)
IL (1) IL165558A0 (da)
IN (1) IN2004CH02747A (da)
MA (1) MA27232A1 (da)
MX (1) MXPA04011984A (da)
NO (1) NO20050087L (da)
NZ (1) NZ537004A (da)
PL (1) PL372117A1 (da)
PT (1) PT1513800E (da)
RU (1) RU2004139122A (da)
SI (1) SI1513800T1 (da)
TW (1) TW200404763A (da)
WO (1) WO2003104188A1 (da)
ZA (1) ZA200408887B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10302452B4 (de) * 2003-01-23 2005-02-24 Aventis Pharma Deutschland Gmbh Carbonylamino-substituierte Acyl-phenyl-harnstoffderivate, Verfahren zu deren Herstellung und deren Verwendung
US7179941B2 (en) 2003-01-23 2007-02-20 Sanofi-Aventis Deutschland Gmbh Carbonylamino-substituted acyl phenyl urea derivatives, process for their preparation and their use
DE10306502B4 (de) * 2003-02-17 2005-03-17 Aventis Pharma Deutschland Gmbh Substituierte 3-(Benzoylureido)-thiophenderivate und sie enthaltende Arzneimittel
DE10308352A1 (de) 2003-02-27 2004-09-09 Aventis Pharma Deutschland Gmbh Arylcycloalkylderivate mit verzweigten Seitenketten, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
DE10308351A1 (de) 2003-02-27 2004-11-25 Aventis Pharma Deutschland Gmbh 1,3-substituierte Cycloalkylderivate mit sauren, meist heterocyclischen Gruppen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US7148246B2 (en) 2003-02-27 2006-12-12 Sanofi-Aventis Deutschland Gmbh Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals
DE10308353A1 (de) 2003-02-27 2004-12-02 Aventis Pharma Deutschland Gmbh Diarylcycloalkylderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE10308355A1 (de) 2003-02-27 2004-12-23 Aventis Pharma Deutschland Gmbh Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
DE10335092B3 (de) 2003-08-01 2005-02-03 Aventis Pharma Deutschland Gmbh Substituierte Benzoylureido-o-benzoylamide, Verfahren zu deren Herstellung und deren Verwendung
US7241787B2 (en) 2004-01-25 2007-07-10 Sanofi-Aventis Deutschland Gmbh Substituted N-cycloexylimidazolinones, process for their preparation and their use as medicaments
EP1586573B1 (en) 2004-04-01 2007-02-07 Sanofi-Aventis Deutschland GmbH Oxadiazolones, processes for their preparation and their use as pharmaceuticals
WO2006055462A1 (en) 2004-11-15 2006-05-26 Bristol-Myers Squibb Company 2-amino-4-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors
US7223786B2 (en) 2004-11-15 2007-05-29 Bristol-Myers Squibb Company 2-aminonaphthalene derivatives and related glycogen phosphorylase inhibitors
US7365061B2 (en) 2004-11-15 2008-04-29 Bristol-Myers Squibb Company 2-Amino-3-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors
US7214704B2 (en) 2004-11-15 2007-05-08 Bristol-Myers Squibb Company 2-Amino-1-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors
DE102005026762A1 (de) 2005-06-09 2006-12-21 Sanofi-Aventis Deutschland Gmbh Azolopyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
TW200718691A (en) 2005-06-10 2007-05-16 Sigma Tau Ind Farmaceuti Cinnamic and phenylpropiolic acid derivatives useful as anti-tumour agents
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL141381B (nl) * 1963-09-25 1974-03-15 Hoechst Ag Werkwijze voor het bereiden van geneesmiddelen met bloedsuikerspiegel verlagende werkzaamheid.
AU601145B2 (en) * 1985-03-01 1990-09-06 Duphar International Research B.V. Benzoyl urea derivatives having anti-tumor activity
ZA867420B (en) * 1985-09-30 1987-05-27 Union Carbide Corp Pesticidal 1-(4-aryloxyphenyl)-3-benzoyl urea compounds and process for preparation
DE4037112A1 (de) * 1990-11-22 1992-05-27 Thomae Gmbh Dr K Neue pyridylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
GB9313268D0 (en) * 1993-06-28 1993-08-11 Zeneca Ltd Chemical compounds
DK0832066T3 (da) * 1995-06-06 2001-11-19 Pfizer Substituerede N-(indol-2-carbonyl)amider og derivater som glycogenphosphorylaseinhibitorer
UY26615A1 (es) * 2000-03-16 2001-10-25 Pfizer Prod Inc Inhibidor de la glucogeno fosforilasa.
DE50102147D1 (de) * 2000-06-09 2004-06-03 Aventis Pharma Gmbh Acylphenylharnstoffderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
GB0021831D0 (en) * 2000-09-06 2000-10-18 Astrazeneca Ab Chemical compounds

Also Published As

Publication number Publication date
HRP20041161A2 (en) 2005-04-30
TW200404763A (en) 2004-04-01
BR0311646A (pt) 2005-03-15
ATE345326T1 (de) 2006-12-15
SI1513800T1 (sl) 2007-04-30
IN2004CH02747A (da) 2006-02-10
HRPK20041161B3 (en) 2006-09-30
JP4398859B2 (ja) 2010-01-13
AU2003238373A1 (en) 2003-12-22
MXPA04011984A (es) 2005-03-07
CN1659137A (zh) 2005-08-24
MA27232A1 (fr) 2005-02-01
KR20050004295A (ko) 2005-01-12
EP1513800B1 (de) 2006-11-15
DE10225635C1 (de) 2003-12-24
PT1513800E (pt) 2007-02-28
ES2277082T3 (es) 2007-07-01
NO20050087L (no) 2005-01-06
WO2003104188A1 (de) 2003-12-18
NZ537004A (en) 2006-06-30
IL165558A0 (en) 2006-01-15
DE50305693D1 (de) 2006-12-28
JP2005529164A (ja) 2005-09-29
RU2004139122A (ru) 2005-06-10
ZA200408887B (en) 2005-11-23
CY1106003T1 (el) 2011-04-06
PL372117A1 (en) 2005-07-11
CA2488760A1 (en) 2003-12-18
EP1513800A1 (de) 2005-03-16

Similar Documents

Publication Publication Date Title
TNSN04199A1 (en) Acyl-4-carboxyphenylurea derivatives, processes for preparing them and their use
RS115004A (en) Novel thiophenylglycoside derivatives,methods for production thereof, medicaments comprising said compounds and use thereof
MXPA03009840A (es) Derivados de fenilurea sustituidos con carboxamida y metodo para la produccion de los mismos como farmacos.
DK1513800T3 (da) Benzoylureido-kanelsyrederivater, fremgangsmåde til deres anvendelse
UA86760C2 (ru) Замещенные n-арилгетероциклы, способ их получения и их применение в качестве лекарственных средств
TNSN06409A1 (en) Novel fluoroglycoside derivatives of pyrazoles, medicaments containing these compounds, and the use thereof
NO20012158L (no) Substituerte 2-fenylbenzimidazoler, fremgangsmåte til fremstilling og anvendelse derav
RS20050019A (en) Heterocyclically substituted benzoylureas,method for their production and their use as medicaments
CY1106752T1 (el) Διϋδροπτεριδινονες, μεθοδος για την παραγωγη τους και χρηση τους ως φαρμακων
MY139302A (en) Novel heterocyclic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof
UA83875C2 (ru) Производные хинолина для применения в качестве микобактериальных ингибиторов
NO20070089L (no) DPP-IV inhibitorer
TW200738692A (en) New substituted glycinamides, process for their manufacture and use thereof as medicaments
EA200600621A1 (ru) Производные тетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
CY1111327T1 (el) Υποκατεστημενα παραγωγα κυκλοεξυλοξεικου οξεος
IL176914A0 (en) Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments
IL176915A0 (en) Cycloalkyl substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments
ATE438617T1 (de) Substituierte cyclohexyl-1,4-diamin-derivate
IL166057A0 (en) Urea-substituted and urethane-substituted acylureas methods for the production thereof and their useas medicaments
RS88704A (en) Acyl-3-carboxyphenylurea derivatives, method for production and use thereof
CO5690587A2 (es) Derivados de acido bensoilureidopiridil-piperidin-y pirrolidin carboxilico sustituido, metodo para su produccion y su uso
ATE471312T1 (de) Diaryltriazolmethylamin-derivate sowie ihre herstellung und therapeutische verwendung
TNSN06233A1 (en) 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments
WO2003070696A3 (de) Substituierte arylketone
MY139549A (en) Dihydropteridinones, method for the production and use thereof in the form of drugs